In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, SpringWorks Therapeutics Inc (NASDAQ: SWTX) closed at $42.89 up 6.96% from its previous closing price of $40.10. In other words, the price has increased by $6.96 from its previous closing price. On the day, 0.87 million shares were traded. SWTX stock price reached its highest trading level at $43.42 during the session, while it also had its lowest trading level at $40.15.
Ratios:
For a deeper understanding of SpringWorks Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.37 and its Current Ratio is at 6.41. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on February 05, 2024, initiated with a Buy rating and assigned the stock a target price of $75.
On December 01, 2022, BofA Securities started tracking the stock assigning a Buy rating and target price of $45.
H.C. Wainwright reiterated its Buy rating for the stock on January 19, 2021, while the target price for the stock was revised from $87 to $101.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 16 ’24 when Pichl Daniel sold 15,000 shares for $50.10 per share. The transaction valued at 751,550 led to the insider holds 45,212 shares of the business.
Ashar Bhavesh sold 4,834 shares of SWTX for $238,435 on Feb 05 ’24. The Chief Commercial Officer now owns 58,154 shares after completing the transaction at $49.32 per share. On Feb 02 ’24, another insider, Pichl Daniel, who serves as the Chief People Officer of the company, sold 26,181 shares for $44.32 each. As a result, the insider received 1,160,362 and left with 45,212 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SWTX now has a Market Capitalization of 3176429312 and an Enterprise Value of 2687990784. For the stock, the TTM Price-to-Sale (P/S) ratio is 580.71 while its Price-to-Book (P/B) ratio in mrq is 5.03. Its current Enterprise Value per Revenue stands at 493.481 whereas that against EBITDA is -7.875.
Stock Price History:
The Beta on a monthly basis for SWTX is 0.87, which has changed by 0.78410983 over the last 52 weeks, in comparison to a change of 0.23061275 over the same period for the S&P500. Over the past 52 weeks, SWTX has reached a high of $53.92, while it has fallen to a 52-week low of $18.00. The 50-Day Moving Average of the stock is -10.27%, while the 200-Day Moving Average is calculated to be 26.25%.
Shares Statistics:
For the past three months, SWTX has traded an average of 1.12M shares per day and 749600 over the past ten days. A total of 73.49M shares are outstanding, with a floating share count of 63.10M. Insiders hold about 14.48% of the company’s shares, while institutions hold 91.50% stake in the company. Shares short for SWTX as of 1711584000 were 10657170 with a Short Ratio of 9.51, compared to 1709164800 on 11125589. Therefore, it implies a Short% of Shares Outstanding of 10657170 and a Short% of Float of 17.43.
Earnings Estimates
The stock of SpringWorks Therapeutics Inc (SWTX) is currently being evaluated by 6 analysts who are actively contributing to its market rating.On average, analysts expect EPS of $-1.19 for the current quarter, with a high estimate of $-0.93 and a low estimate of $-1.35, while EPS last year was $-1.18. The consensus estimate for the next quarter is $1.75, with high estimates of $16.1 and low estimates of $-1.33.
Analysts are recommending an EPS of between $-3.05 and $-5.97 for the fiscal current year, implying an average EPS of $-4.71. EPS for the following year is $-3.5, with 5 analysts recommending between $-0.47 and $-4.42.
Revenue Estimates
A total of 8 analysts have provided revenue estimates for SWTX’s current fiscal year. The highest revenue estimate was $127.7M, while the lowest revenue estimate was $54.2M, resulting in an average revenue estimate of $87.34M. In the same quarter a year ago, actual revenue was $5.45M, up 1,503.50% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $256.3M in the next fiscal year. The high estimate is $376.4M and the low estimate is $190.3M. The average revenue growth estimate for next year is up 193.50% from the average revenue estimate for this year.
